Scotts Miracle-Gro Co (SMG) Receives $104.25 Average Price Target from Analysts

Scotts Miracle-Gro Co (NYSE:SMG) has received a consensus recommendation of “Hold” from the six analysts that are currently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $104.25.

A number of analysts have commented on SMG shares. Zacks Investment Research upgraded shares of Scotts Miracle-Gro from a “sell” rating to a “hold” rating and set a $121.00 price target for the company in a research note on Wednesday, January 10th. KeyCorp reiterated a “hold” rating on shares of Scotts Miracle-Gro in a research note on Saturday, November 25th. Finally, Bank of America set a $120.00 price target on shares of Scotts Miracle-Gro and gave the company a “buy” rating in a research note on Tuesday, January 30th.

How to Become a New Pot Stock Millionaire

Shares of SMG stock traded down $0.61 on Friday, reaching $84.42. 489,186 shares of the company traded hands, compared to its average volume of 480,628. Scotts Miracle-Gro has a fifty-two week low of $81.48 and a fifty-two week high of $110.12. The firm has a market capitalization of $4,805.52, a PE ratio of 19.54, a price-to-earnings-growth ratio of 1.61 and a beta of 0.21. The company has a debt-to-equity ratio of 3.34, a current ratio of 2.09 and a quick ratio of 0.61.

Scotts Miracle-Gro (NYSE:SMG) last announced its earnings results on Tuesday, January 30th. The basic materials company reported ($1.08) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.92) by ($0.16). Scotts Miracle-Gro had a return on equity of 38.33% and a net margin of 9.11%. The business had revenue of $221.50 million for the quarter, compared to analyst estimates of $237.21 million. During the same quarter in the previous year, the company posted ($0.96) EPS. The business’s revenue for the quarter was down 10.3% compared to the same quarter last year. equities research analysts predict that Scotts Miracle-Gro will post 4.7 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, March 9th. Shareholders of record on Friday, February 23rd were paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date was Thursday, February 22nd. Scotts Miracle-Gro’s dividend payout ratio is currently 49.07%.

In other Scotts Miracle-Gro news, Director Katherine Littlefield Hagedorn sold 2,892 shares of the stock in a transaction on Monday, February 5th. The shares were sold at an average price of $89.50, for a total value of $258,834.00. Following the completion of the sale, the director now owns 9,043 shares in the company, valued at $809,348.50. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 29.14% of the company’s stock.

A number of hedge funds have recently made changes to their positions in SMG. Steward Partners Investment Advisory LLC lifted its stake in Scotts Miracle-Gro by 2,291.7% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 1,148 shares of the basic materials company’s stock valued at $122,000 after acquiring an additional 1,100 shares during the last quarter. SeaCrest Wealth Management LLC bought a new position in shares of Scotts Miracle-Gro in the fourth quarter valued at about $172,000. Charter Trust Co. bought a new position in shares of Scotts Miracle-Gro in the fourth quarter valued at about $203,000. Carnick & Kubik Group LLC bought a new position in shares of Scotts Miracle-Gro in the fourth quarter valued at about $209,000. Finally, Narwhal Capital Management bought a new position in shares of Scotts Miracle-Gro in the fourth quarter valued at about $214,000. Hedge funds and other institutional investors own 66.63% of the company’s stock.

WARNING: “Scotts Miracle-Gro Co (SMG) Receives $104.25 Average Price Target from Analysts” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another publication, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3300513/scotts-miracle-gro-co-smg-receives-104-25-average-price-target-from-analysts.html.

About Scotts Miracle-Gro

The Scotts Miracle-Gro Company (Scotts Miracle-Gro) is a manufacturer and marketer of branded consumer lawn and garden products. The Company’s segments include Global Consumer. In North America, its brands include Scotts and Turf Builder lawn and grass seed products; Miracle-Gro, Nature’s Care, Scotts, LiquaFeed and Osmocote gardening and landscape products; and Ortho, Roundup, Home Defense and Tomcat branded insect control, weed control and rodent control products.

Receive News & Ratings for Scotts Miracle-Gro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scotts Miracle-Gro and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Q2 2018 EPS Estimates for Independent Bank Co.  Lifted by Analyst
Q2 2018 EPS Estimates for Independent Bank Co. Lifted by Analyst
OFG Bancorp  to Post Q2 2018 Earnings of $0.25 Per Share, Piper Jaffray Forecasts
OFG Bancorp to Post Q2 2018 Earnings of $0.25 Per Share, Piper Jaffray Forecasts
Q2 2018 EPS Estimates for Southwestern Energy Boosted by Analyst
Q2 2018 EPS Estimates for Southwestern Energy Boosted by Analyst
Energous  Upgraded by BidaskClub to “Buy”
Energous Upgraded by BidaskClub to “Buy”
Precision Drilling  to Release Earnings on Thursday
Precision Drilling to Release Earnings on Thursday
CRISPR Therapeutics  Downgraded to “Buy” at BidaskClub
CRISPR Therapeutics Downgraded to “Buy” at BidaskClub


© 2006-2018 Ticker Report. Google+.